Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2025-12-24 @ 2:35 PM
NCT ID:
NCT02382159
Eligibility Criteria:
Inclusion Criteria:
Among the patients, who has been hospitalized or visited the Outpatient Department OPD, who has dyslipidemia of type 2 diabetes.
1. Patients have the result of lipid parameter test at baseline and after lipid-lowering drug for at least 3 months.
2. Patients who have the result of lipid paraneter test (LDL-C ≥100mg/dL, TG ≥150mg/dL) at baseline.
3. Patients who have no received lipid lowering drug fr at least 2 months prior to the baseline.
4. Patients' age were \> 20 years and \<75 year.
Exclusion Criteria:
1. Patients who ahs HbA1c≥9%
2. Patients who have no the result of lipid parameter test at baseline and at baseline and after lipid-lowering drug for at least 3 months
3. Patients who have history of drug discontinuation by incresed liver enzyme or rhabdomyolysis.
4. Patients received lipid-lowering drug and TZD(Thiazolidinediones) in study period
5. Renal abnormality
6. Alcoholism or Alcohol abuse
7. Patients treated by Steroids.
8. Pregnant or lactating woman
9. Patients who are judged as not suitable for this study by Investigator.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT02382159
Study Brief:
Protocol Section:
NCT02382159